Tyrosine hydroxylase is expressed during early heart development and is required for cardiac chamber formation

Cardiovascular Research

Volumn 88, Issue 1, 2010, Pages 111-120

  López Sánchez, Carmen ^a   Bártulos, Óscar ^b   Martínez Campos, Enrique ^b   Gañán, Carlos ^a   Valenciano, Ana I ^c   García Martínez, Virginio ^a   De Pablo, Flora ^b,d   Hernández Sánchez, Catalina ^b,d  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cardiogenesis; Dopamine; L DOPA; Tyrosine hydroxylase

Indexed keywords

ATRIAL MYOSIN; DOPAMINE; LEVODOPA; MYOSIN HEAVY CHAIN; RETINOIC ACID; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR TBX5; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; BRADYCARDIA; DOPAMINE METABOLISM; ENDOCARDIUM; GASTRULATION; HEART ATRIUM; HEART DEVELOPMENT; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN SITU HYBRIDIZATION; MESODERM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMERE; SPLANCHNIC BLOOD FLOW;

ANIMALS; ATRIAL MYOSINS; AVIAN PROTEINS; BODY PATTERNING; CATECHOLAMINES; CELL DIFFERENTIATION; CHICK EMBRYO; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; ELECTROPORATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; GENE TRANSFER TECHNIQUES; HEART; HEART RATE; HOMEODOMAIN PROTEINS; IN SITU HYBRIDIZATION; LEVODOPA; MORPHOGENESIS; MYOCARDIUM; MYOSIN HEAVY CHAINS; OLIGONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-BOX DOMAIN PROTEINS; TISSUE CULTURE TECHNIQUES; TRETINOIN; TYROSINE 3-MONOOXYGENASE;

EID: 77956814612     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq179     Document Type: Article

References (41)

1. Fitzpatrick PF. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 1999;68:355-381.
2. Pendleton RG, Rasheed A, Roychowdhury R, Hillman R. A new role for catechol-amines: ontogenesis. Trends Pharmacol Sci 1998;19:248-251.
3. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I et al. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 1995;270:27235-27243.
4. Thomas SA, Matsumoto AM, Palmiter RD. Noradrenaline is essential for mouse fetal development. Nature 1995;374:643-646.
5. Zhou QY, Quaife CJ, Palmiter RD. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 1995;374:640-643.
6. Portbury AL, Chandra R, Groelle M, McMillian MK, Elias A, Herlong JR et al. Catechol-amines act via a beta-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 2003;284:H2069-2077.
7. Ream MA, Chandra R, Peavey M, Ray AM, Roffler-Tarlov S, Kim HG et al. High oxygen prevents fetal lethality due to lack of catecholamines. Am J Physiol Regul Integr Comp Physiol 2008;295:R942-953.
8. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005;6:826-835.
9. Moorman AF, Christoffels VM. Cardiac chamber formation: development, genes, and evolution. Physiol Rev 2003;83:1223-1267.
10. Oana S, Machida S, Hiratsuka E, Furutani Y, Momma K, Takao A et al. The complete sequence and expression patterns of the atrial myosin heavy chain in the developing chick. Biol Cell 1998;90:605-613.
11. Somi S, Klein AT, Houweling AC, Ruijter JM, Buffing AA, Moorman AF et al. Atrial and ventricular myosin heavy-chain expression in the developing chicken heart: strengths and limitations of non-radioactive in situ hybridization. J Histochem Cytochem 2006;54: 649-664.
12. Yutzey KE, Rhee JT, Bader D. Expression of the atrial-specific myosin heavy chain AMHC1 and the establishment of anteroposterior polarity in the developing chicken heart. Development 1994;120:871-883.
13. Hernandez-Sanchez C, Bartulos O, Valenciano AI, Mansilla A, De Pablo F. The regulated expression of chimeric tyrosine hydroxylase-insulin transcripts during early development. Nucleic Acids Res 2006;34:3455-3464.
14. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG et al. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 1999; 211:100-108.
15. Christoffels VM, Habets PE, Franco D, Campione M, De Jong F, Lamers WH et al. Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol 2000;223:266-278.
16. Liberatore CM, Searcy-Schrick RD, Yutzey KE. Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol 2000;223:169-180.
17. Dunkley PR, Bobrovskaya L, Graham ME, Von Nagy-Felsobuki EI, Dickson PW. Tyro-sine hydroxylase phosphorylation: regulation and consequences. J Neurochem 2004; 91:1025-1043.
18. Ignarro LJ, Shideman FE. Appearance and concentrations of catecholamines and their biosynthesis in the embryonic and developing chick. J Pharmacol Exp Ther 1968;159: 38-48.
19. Zaffran S, Frasch M. Early signals in cardiac development. Circ Res 2002;91:457-469.
20. Bao ZZ, Bruneau BG, Seidman JG, Seidman CE, Cepko CL. Regulation of chamber-specific gene expression in the developing heart by Irx4. Science 1999;283: 1161-1164.
21. Hochgreb T, Linhares VL, Menezes DC, Sampaio AC, Yan CY, Cardoso WV et al. A caudorostral wave of RALDH2 conveys anteroposterior information to the cardiac field. Development 2003;130:5363-5374.
22. Xavier-Neto J, Rosenthal N, Silva FA, Matos TG, Hochgreb T, Linhares VL. Retinoid signaling and cardiac anteroposterior segmentation. Genesis 2001;31:97-104.
23. Niederreither K, Vermot J, Messaddeq N, Schuhbaur B, Chambon P, Dolle P. Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. Development 2001;128:1019-1031. (Pubitemid 32401419)
24. Xavier-Neto J, Neville CM, Shapiro MD, Houghton L, Wang GF, Nikovits W Jr et al.A retinoic acid-inducible transgenic marker of sino-atrial development in the mouse heart. Development 1999;126:2677-2687.
25. Gelain DP, Moreira JC, Bevilaqua LR, Dickson PW, Dunkley PR. Retinol activates tyro-sine hydroxylase acutely by increasing the phosphorylation of serine40 and then serine31 in bovine adrenal chromaffin cells. J Neurochem 2007;103:2369-2379.
26. Jeong H, Kim MS, Kim SW, Kim KS, Seol W. Regulation of tyrosine hydroxylase gene expression by retinoic acid receptor. J Neurochem 2006;98:386-394.
27. Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997;15:30-35.
28. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S et al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001;106:709-721.
29. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet 1997;15:21-29.
30. Buck SH, Konyn PJ, Palermo J, Robbins J, Moss RL. Altered kinetics of contraction of mouse atrial myocytes expressing ventricular myosin regulatory light chain. Am J Physiol 1999;276:H1167-H1171.
31. Chen J, Kubalak SW, Minamisawa S, Price RL, Becker KD, Hickey R et al. Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem 1998;273:1252-1256.
32. Pawloski-Dahm CM, Song G, Kirkpatrick DL, Palermo J, Gulick J, Dorn GW 2nd et al. Effects of total replacement of atrial myosin light chain-2 with the ventricular isoform in atrial myocytes of transgenic mice. Circulation 1998;97:1508-1513.
33. Kamino K, Hirota A, Fujii S. Localization of pacemaking activity in early embryonic heart monitored using voltage-sensitive dye. Nature 1981;290:595-597.
34. Pollack GH. Cardiac pacemaking: an obligatory role of catecholamines? Science 1977; 196:731-738.
35. Ebert SN, Taylor DG. Catecholamines and development of cardiac pacemaking: an intrinsically intimate relationship. Cardiovasc Res 2006;72:364-374.
36. Zhou QY, Palmiter RD. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 1995;83:1197-1209.
37. Ebert SN, Thompson RP. Embryonic epinephrine synthesis in the rat heart before innervation: association with pacemaking and conduction tissue development. Circ Res 2001;88:117-124.
38. Huang MH, Friend DS, Sunday ME, Singh K, Haley K, Austen KF et al. An intrinsic adrenergic system in mammalian heart. J Clin Invest 1996;98:1298-1303.
39. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006;126:1037-1048.
40. Hernandez-Sanchez C, Mansilla A, De la Rosa EJ, De Pablo F. Proinsulin in development: New roles for an ancient prohormone. Diabetologia 2006;49:1142-1150.
41. Sanders EJ, Harvey S. Peptide hormones as developmental growth and differentiation factors. Dev Dyn 2008;237:1537-1552.